Curatia Medical Inc.

About Curatia Medical Inc.

Curatia Medical Inc. (迪泰医学) was established in 2015 with headquarters in Sunnyvale, California, USA and a wholly-owned manufacturing subsidiary in Suzhou, China. The company is dedicated to the design, manufacture, and global sale of disposable high-value interventional consumables for cardiology, peripheral vascular, neurology, and pulmonary applications. Its mission is to become the worldwide leader in “intervention-without-implant” access solutions.

Core Business & Key Technologies

Curatia’s core business centers on Class II/III disposable interventional devices. Key technologies include multi-layer co-extrusion polymer tubing, laser welding, stainless-steel or Nitinol wire braiding, hydrophilic coatings, and radiopaque marker bands. All manufacturing is performed in ISO 13485-certified cleanrooms (Class 10 k/100 k) under FDA QSR, EU MDR, NMPA, Korean GMP, and ISO 13485:2016 standards.

Market Position & Flagship Products

Curatia is recognized as a tier-one global supplier of vascular-access devices, with products sold in over 40 countries across North America, Europe, South America, and Asia. Flagship product lines include:

• URSA® – diagnostic angiographic catheters

• XCESS® – guiding catheters

• EXTESIA® – introducer long-sheath systems

• VELA™ RX / NAVAJO™ – high-pressure PTA balloon catheters (rated ≥30 atm)

• AutoSeal™ – disposable Y-type hemostasis valve kits

• HW-Flex™ – distal access catheter for neuro-intervention (FDA clearance pending)

All devices are CE-marked and FDA 510(k) cleared. The company also provides OEM/ODM services for leading global brands.

Contact Information

Address (HQ): 1255 Reamwood Avenue, Suite 110, Sunnyvale, CA 94089, USA

Address (china): 198 Xiangjiang Road, Suzhou New District, Suzhou 215129, China

Phone: +1 408 414 2188 (USA) / +86 512 6680 6620 (China)

Email: sales@curatiamed.com